These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20615923)

  • 1. Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas.
    Andreiuolo F; Puget S; Peyre M; Dantas-Barbosa C; Boddaert N; Philippe C; Mauguen A; Grill J; Varlet P
    Neuro Oncol; 2010 Nov; 12(11):1126-34. PubMed ID: 20615923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression.
    Hagel C; Treszl A; Fehlert J; Harder J; von Haxthausen F; Kern M; von Bueren AO; Kordes U
    J Neurooncol; 2013 Apr; 112(2):191-7. PubMed ID: 23371454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of H3K27me3 in children with ependymoma.
    Han Z; Kang P; Zhang H; Liao Z; Li C; Gong J; Liu W; Tian Y
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28121. PubMed ID: 31850684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both location and age predict survival in ependymoma: a SEER study.
    McGuire CS; Sainani KL; Fisher PG
    Pediatr Blood Cancer; 2009 Jan; 52(1):65-9. PubMed ID: 19006249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study.
    Aizer AA; Ancukiewicz M; Nguyen PL; Macdonald SM; Yock TI; Tarbell NJ; Shih HA; Loeffler JS; Oh KS
    J Neurooncol; 2013 Dec; 115(3):411-9. PubMed ID: 24057324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
    Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
    Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factor evi-1 is overexpressed, promotes proliferation, and is prognostically unfavorable in infratentorial ependymomas.
    Koos B; Bender S; Witt H; Mertsch S; Felsberg J; Beschorner R; Korshunov A; Riesmeier B; Pfister S; Paulus W; Hasselblatt M
    Clin Cancer Res; 2011 Jun; 17(11):3631-7. PubMed ID: 21493867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic analysis of ependymoma in childhood].
    Zhou B; Li J; Luo Z
    Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):369-71. PubMed ID: 8732095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.
    Virág J; Haberler C; Baksa G; Piurkó V; Hegedüs Z; Reiniger L; Bálint K; Chocholous M; Kiss A; Lotz G; Glasz T; Schaff Z; Garami M; Hegedűs B
    Pathol Oncol Res; 2017 Apr; 23(2):245-252. PubMed ID: 27395057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
    Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
    PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of copy number variants in the classification of intracranial ependymoma.
    Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S
    Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups.
    Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J
    J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
    de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
    Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.
    Massimino M; Gandola L; Barra S; Giangaspero F; Casali C; Potepan P; Di Rocco C; Nozza P; Collini P; Viscardi E; Bertin D; Biassoni V; Cama A; Milanaccio C; Modena P; Balter R; Tamburrini G; Peretta P; Mascarin M; Scarzello G; Fidani P; Milano GM; Sardi I; Genitori L; Garrè ML
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):807-14. PubMed ID: 20646868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
    Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
    J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.
    Panwalkar P; Clark J; Ramaswamy V; Hawes D; Yang F; Dunham C; Yip S; Hukin J; Sun Y; Schipper MJ; Chavez L; Margol A; Pekmezci M; Chung C; Banda A; Bayliss JM; Curry SJ; Santi M; Rodriguez FJ; Snuderl M; Karajannis MA; Saratsis AM; Horbinski CM; Carret AS; Wilson B; Johnston D; Lafay-Cousin L; Zelcer S; Eisenstat D; Silva M; Scheinemann K; Jabado N; McNeely PD; Kool M; Pfister SM; Taylor MD; Hawkins C; Korshunov A; Judkins AR; Venneti S
    Acta Neuropathol; 2017 Nov; 134(5):705-714. PubMed ID: 28733933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
    Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
    Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and survival of supratentorial and posterior fossa ependymomas in adults.
    Nuño M; Yu JJ; Varshneya K; Alexander J; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2016 Jun; 28():24-30. PubMed ID: 26810473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of supratentorial ependymomas.
    Chakraborty A; Harkness W; Phipps K
    Childs Nerv Syst; 2009 Oct; 25(10):1215-20. PubMed ID: 19357853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.